age related macular degeneration (amd)

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)

Not yet recruiting
  • Age Related Macular Degeneration (AMD)
  • SPIN
  • Non-aerobic, stretching/balance intervention Control
  • Decatur, Georgia
    Atlanta VA Medical and Rehab Center, Decatur, GA
Jun 26, 2023

ORACLE: A Long-term Follow-up Study to Evaluate Safety and

Enrolling by invitation
  • Age Related Macular Degeneration (AMD)
  • GT005
  • Reno, Nevada
    Sierra Eye Associates
Aug 9, 2022

Development of Novel Clinical Endpoints in Intermediate AMD

Active, not recruiting
  • Age Related Macular Degeneration (AMD)
  • No intervention
  • Copenhagen, Denmark
  • +19 more
May 23, 2022

Production of iPSC Derived RPE Cells for Transplantation in AMD

Completed
  • Age Related Macular Degeneration (AMD)
    • (no location specified)
    Apr 4, 2022

    Age Related Macular Degeneration (AMD) Trial in United States (Health Management Tool (HMT))

    Completed
    • Age Related Macular Degeneration (AMD)
    • Health Management Tool (HMT)
    • Beverly Hills, California
    • +22 more
    Jul 10, 2018

    Age Related Macular Degeneration (AMD) Trial in Remuera, Auckland (Lucentis, PF582)

    Completed
    • Age Related Macular Degeneration (AMD)
    • Remuera, Auckland, New Zealand
    • +1 more
    May 9, 2016

    Age Related Macular Degeneration (AMD), Macular Degeneration, Choroidal Neovascularization (CNV) Trial in Worldwide (Pegaptanib

    Terminated
    • Age Related Macular Degeneration (AMD)
    • +2 more
    • Pegaptanib Sodium 0.3 mg
    • Graz, Austria
    • +57 more
    Apr 2, 2012